APNA 28th Annual Conference Session 1024: October 22, 2014
|
|
- Betty Riley
- 5 years ago
- Views:
Transcription
1 Therapeutic Neuromodulation: Implications for Psychiatric Mental Health (PMH) Nurses Mary Rosedale PhD, PMHNP BC Donna Ecklesdafer, MSN, BSN, RN Dawn Miller, BSN, RN Julie Ann Mulder MS, BSN, BS, RN BC 1 Disclosures Mary Rosedale: Edith L. Fisch Award for Innovation in Neurostimulation, New York University, School of Medicine NYU College of Nursing Pless Center for Nursing Research CTSI Grant # 5UL1RR Supported in part by grant 1UL1RR from the National Center for Research Resources, National Institutes of Health No Conflict of Interest to disclose for the other presenters. Objectives Objective 1 Examine the neurobiology of brain stimulation Objective 2 Explore the safety and efficacy of Deep Brain Stimulation (DBS), Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Deep TMS, Magnetic Seizure Therapy (MST), Vagus Nerve Stimulation (VNS) and Transcranial Direct Current Stimulation (tdcs) Objective 3 Explain the role of PMH nurses in practice, education and research in neuromodulation The Brain as an Electrical and Chemical Organ 100 billion neurons 100 trillion connections Interaction is a combination of electrical and chemical interaction An electrical impulse along an axon Excitatory or inhibitory Threshold= The level of stimulation needed to trigger an action potential 4 5 Brain Stimulation Techniques Electroconvulsive Therapy (ECT) Vagus Nerve Stimulation (VNS) Repetitive Transcranial Magnetic Stimulation (rtms) Deep Brain Stimulation (DBS) Epidural Cortical Stimulation (EpCS) Transcranial Direct Current Stimulation (tdcs) 6 Ecklesdafer, Rosedale, Miller, Mulder 1
2 Survey of the major neurotransmitters excitatory presynaptic neuron Inhibitory GABA presynaptic neuron Inhibitory neurotrans mission prevents excitation of the postsynaptic neuron Postsynaptic neuron inhibitory Mayberg, HS, 1999 Drevets, WC 2001 Ecklesdafer, Rosedale, Miller, Mulder 2
3 Depression Cerebral blood flow & Metabolism Hippocampal volume Serotonin Dopamine Neurogenesis & Neuroplasticity Neuroplasticity The ability of the neural pathways and synapses to adapt to stimuli by reorganizing structurally and functionally. 13 Neurogenesis The birth of new neurons mostly known to occur in the dentate gyrus of the hippocampal formation. 14 ECT Plasma prolactin levels Thyrotropin releasing hormone (TRH) TRH receptor function Brain derived neurotrophic factor (BDNF) TMS Cerebral blood flow in the prefrontal & paralimbic areas Dopamine Serotonin Thyroid stimulating hormone (TSH) Glutamate levels GABA Electroconvulsive Therapy (ECT) Donna Ecklesdafer, MSN, BSN, RN ECT Clinic Manager Pine Rest Christian Mental Health Services Ecklesdafer, Rosedale, Miller, Mulder 3
4 Diagnoses Diagnoses Major Depression (+/- psychosis) Other diagnoses Bipolar Depression and Mania Schizoaffective Catatonia 19 Neuroleptic Malignant Syndrome Dementia with underlying mood disorder Current research project Short-term Efficacy and Cognitive Side Effects of Acute Electroconvulsive Therapy for Agitation and Aggression in Dementia 20 Life Saving Treatment Actively Suicidal Rapid Response Needed Suicide (American Association of Suicidology) Completed suicide: 38,364 cases reported in Suicide (American Association of Suicidology) Average of 1 person every 13.7 minutes killed themselves Average of 1 elderly person every 1 hour and 28 minutes killed themselves Average of 1 young person every 1 hour and 54 minutes killed themselves Adding the 274 suicides below age 15, the rate would be 1 young person every 1 hour and 48 minutes 22 Suicide (American Association of Suicidology) Suicide is the 10 th ranking cause of death in U.S. Homicide ranks 16th Suicide is the 3 rd highest cause of death for young (ages 15 24) 1 st accidents: 12,951 2 nd homicide: 4,678 3 rd suicide: 4, Improvements in ECT Medications Anesthesia Muscle Relaxant Oxygenation Administration of oxygen Monitor oxygen saturation 24 Ecklesdafer, Rosedale, Miller, Mulder 4
5 Improvements in ECT Stimulus Electrode Placements Type of electricity brief pulse wave Seizure monitoring Stimulus dosing Bi-temporal Right Unilateral Bifrontal Ultra brief pulse Seizure Monitoring Seizure length seconds Tonic/Clonic (Peripheral seizure) ECT Treatments Acute Series 3 times each week Typically 6 12 treatments Improvements seen after 4 6 treatments Tachycardia Electroencephalogram (EEG) (Central seizure) 27 Maintenance Weekly to monthly Can prevent inpatient stays 80% of patients relapse after ECT with no follow up of medications or maintenance ECT 28 Seizure Threshold Seizure Threshold Medications that can change seizure threshold Other influences on seizure threshold Lithium Benzodiazepines Mood stabilizers Antipsychotics 29 Age Gender Electrode placement Hyperventilation Dehydration Sleep 30 Ecklesdafer, Rosedale, Miller, Mulder 5
6 Seizures Parasympathetic discharge Anesthesia Anesthetic Brevital or methohexital Sympathetic discharge Etomidate Muscle relaxant succinylcholine (anectine) Potential rebound parasympathetic discharge 31 Depolarizing muscle relaxant Most common cause of muscle soreness 32 Potential Mechanisms of Action Decreases frontal cortical connectivity Neurotransmitter theory Anticonvulsant theory Benefits of ECT Improved mood Increased pleasure More restful sleep Better appetite More positive attitude Less agitation Increased sexual interest More energy Clearer thinking More hope Potential Side Effects Contraindications Headache and muscle aches No absolute contraindications Nausea Unsteady on feet High risk Risk versus benefit Confusion Potential short term and/or long term memory loss 35 Mortality Less than for childbirth 36 Ecklesdafer, Rosedale, Miller, Mulder 6
7 Pre-ECT Workup ECT Procedure Psychiatric referral Basic Metabolic Profile Electrocardiogram History & Physical medical clearance Inpatient versus Outpatient Risk/Benefit Ratio Education Informed Consent 37 Patient and Family rating scale Assessment of patient Intravenous line placement Anesthesia and muscle relaxant Brief electrical stimulus Monitor seizure activity Post Anesthesia Care Unit Vitals stable discharge 38 Transcranial Magnetic Stimulation (TMS) Therapy Transcranial Magnetic Stimulation (TMS) Therapy TMS is a non invasive treatment for Major Depressive Disorder (MDD) in adult patients FDA approved in October 2008 for MDD with one failed antidepressant trial 39 FDA approved in April 2014 for MDD for those who have failed to benefit from any number of antidepressant trials Off label uses: treatment of anxiety disorders, Bipolar Disorder, Post Traumatic Stress Disorder, chronic pain, fibromyalgia, eating disorders, and Parkinson s Disease 40 TMS Therapy Stimulates cortical neurons by delivering magnetic pulses to a specific area of the brain Utilizes a magnetic field generated by a treatment coil applied to the head, usually tesla Neuronetics TMS NeuroStar machine generates 0.5 tesla For comparison, 3.0 T is the strength of magnetic field generated by most medical Magnetic Resonance Imaging (MRI) systems 41 How TMS Works TMS is based on two electromagnetic principles: 1. Ampere s Law: magnetic field generated using alternating an electrical current 2. Faraday s Law: electrical current generated using an alternating magnetic field Electricity passes through the metal coil which is placed directly against the head over the Dorsolateral Prefrontal Cortex (DLPFC) 42 Ecklesdafer, Rosedale, Miller, Mulder 7
8 How TMS Works Electric energy Results in within insulated coil depolarization of induces magnetic nerve cells causing fields release of Magnetic fields neurotransmitters penetrate the cranium cm below the device Magnetic fields induce electric current in the brain 43 Dorsolateral Prefrontal Cortex (DLPFC) TMS produces its effect through electrical stimulation of the DLPFC; this is the area of the brain believed to be responsible for regulating mood. 44 Early Transcranial Magnetic Stimulation 45 Identifying TMS Treatment Location Coil is applied to the Primary Motor Cortex to initiate a thumb twitch response; this is called the Motor Threshold (MT) MT determines the energy required to effectively treat depression and helps identify the location of the DLPFC Coil is placed 5.5 cm anterior to the location of the MT 46 Primary Motor Strip and Homunculus 47 TMS Administration TMS sessions: 1 per day for 4 6 weeks (typically Monday through Friday) Typical series is 30 treatments Treatments last approximately 40 minutes Patient positioning & Motor Threshold is determined Recommended Intensity: 120% of MT Frequency: pulses per second (10 Hz or 1 Hz) Treatment train: 4 seconds of stimulation with 26 seconds of no stimulus; 3000 total pulses per treatment 48 Ecklesdafer, Rosedale, Miller, Mulder 8
9 NeuroStar TMS Therapy System Treatment Coil Display Brainsway TMS System Deep TMS (dtms) Magnetic field penetrates cm Senstar Treatment Link Mobile Console Patient Selection for TMS Absolute Contraindications: Patients with MDD who have failed trials of antidepressant medications at or above minimally effective dose, for a minimal duration (at least 4 weeks) in the current episode of MDD Patients who have been carefully screened for any of the absolute contraindications to receiving TMS Patients who are willing and able to commit to treatments five days a week for 4 6 weeks 51 Seizure disorder or history of seizures (except those induced by ECT) Intracranial devices (cerebrospinal fluid shunts, aneurysm clips, cochlear implants, deep brain stimulation leads, etc.) Carotid or cerebral stents Space occupying brain lesions Evidence of increased intracranial pressure 52 Absolute Contraindications: Relative Contraindications Vagus nerve stimulator Ferromagnetically ocular implants Magnetically activated dental implants Facial tattoos or permanent makeup with metallic ink less than or equal to 30cm from the coil Pellets, bullets, or metallic fragments less than or equal to 30cm from coil 53 Dementia & other degenerative neurological conditions (i.e. Parkinson s, Multiple Sclerosis, etc.) Unstable medical conditions Chronic or acute psychotic disorders (i.e. Schizophrenia, Schizophreniform, Schizoaffective disorders, etc.) 54 Ecklesdafer, Rosedale, Miller, Mulder 9
10 Relative Contraindications Clinical Considerations Serious co morbid psychiatric conditions (i.e. psychotic depression, active substance abuse, etc.) History of cerebrovascular accident Implantable automatic defibrillator or cardiac pacemaker History of significant head injury resulting in loss of consciousness greater than 5 minutes and/or hospitalization 55 Performed as an outpatient or inpatient procedure Patient is awake, alert during treatment Treatment lasts about 40 minutes, patient resumes normal activity afterwards Many TMS patients continue to take psychotropic medications Several insurance companies provide TMS coverage, either as part of their policy or on a case by case basis 56 TMS Side Effect Profile TMS Side Effect Profile Common Side Effects Scalp discomfort, tenderness at coil placement site Headache, may be managed with an over the counter analgesic Facial pain, muscle twitching These side effects were graded as mild to moderate and dissipated rapidly with time. 57 Rare Side Effect Risk of generalized seizure: 1 in 30,000 treatments or 0.003% To mitigate this risk, patients are carefully screened for seizure history & any conditions/situations that have the potential to alter seizure threshold (i.e. tricyclic antidepressants, neuroleptics, secondary conditions that alter electrolyte imbalance or lower seizure threshold) % TMS Remission Rates: Neuronetics Trial and NIMH OPT TMS Study Response, Remission, Non Response Rates for TMS pts at WRNMMC Response 50% reduction in baseline mood scale score (PHQ 9, QIDS SR): 44.4% of those who responded 60 5% of 4 met criteria for full remission of MDD symptoms Remission Full resolution of depressive symptoms (PHQ 9 score < 5, QIDS SR < 6) Active Sham Neuronetics Active Sham OPT TMS Non Response rate at WRNMMC after 20+ TMS sessions: 44.4% Ecklesdafer, Rosedale, Miller, Mulder 10
11 TMS Roles TMS machine is a class II device prescribed by a psychiatrist (but each state regulates prescriptive authority which includes Nurse Practitioners) Attending psychiatrist oversees initial patient MT determinations, treatment parameter definitions, & overall TMS treatment course planning Ideally, treatment is administered by a RN who has the ability to manage seizures, monitor psychological status, & has proper training on the TMS device 61 Role of the PMH Nurse in TMS PMH nurse is present throughout treatment, allowing for close monitoring of day to day changes in the patient s condition Administering psychiatric scales to monitor progress Administers daily treatment within prescribed parameters; assures proper patient positioning & proper coil placement Continuously monitors for signs of impending seizure Coordinates care with outpatient providers Crisis intervention as needed (psychiatric and medical) 62 TMS Manufacturers TMS Manufacturers Brainsway (Israel), Neuronetics Inc., Currently the only FDA approved devices are manufactured by Brainsway and Neuronetics. 63 CR Tech (Seoul, South Korea) Magstim Company, Ltd. (Whitland, UK) ww.magstim.com MAG&MORE GmbH, (Munich, Germany) Mcube Technology Co., Ltd. (Seoul, South Korea) Medtronic Dantec NeuroMuscular (Skovlunde, Denmark) Neuralieve (California, USA) Nexstim (Finland) Schwarzer (München, Germany) 64 References 1. Baeken C, De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues in Clinical Neuroscience 2011; 13(1): Barker AT, Jalinous R. Non invasive magnetic stimulation of human motor cortex. Lancet 1985 (May 11, 1985): Zangen, A., Roth, Y., Voller, B., Hallett, M Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of H coil. Journal of Neurophysiology 2005; 116 (4): Dell Osso B, Camuri G, Castellano F, Vecchi V, Benedetti M, Bortolussi S, Altamura AC. Meta review of metanalytic studied with repetitive transcranial magnetic stimulation (rtms) for the treatment of major depression. Clinical Practice & Epidemiology in Mental Health 2011; 7: Epilepsy Foundation of America, Inc Managing seizures: Information for caregivers. 6. George MS, Belmaker RH (editors). Transcranial Magnetic Stimulation in Clinical Psychiatry. Arlington, VA: American Psychiatric Publishing, Higgins ES, George MS. Brain Stimulation Therapies for Clinicians. Washington, DC: American Psychiatric Publishing, Inc., Deep & Cortical Brain Stimulation 66 Medtronic NeuroPace Ecklesdafer, Rosedale, Miller, Mulder 11
12 Bilateral Epidural Prefrontal Cortical Stimulation for TRD Cognition, executive control and integration of emotion: 2 complimentary networks VN S 69 Overlapping Paradigm Shifts in Nursing and Brain Stimulation 50 years is needed to make a paradigm shift In the past 6 decades, Nursing has been transformed from an occupation where nurses do to and for patients, to a profession where nurses work with patients For more than 7 decades, nurses have provided specialized care for ECT patients Brain stimulation therapies are a new therapeutic class and Psychiatric Nursing field 70 Cyberonics, Inc., Houston, TX The Science is Moving at Accelerated Rate: Changing Practice and Knowledge Development tdcs for Depression (Rigonnati et al., 2008 & Fregni et al., 2006 Mayberg et al Ecklesdafer, Rosedale, Miller, Mulder 12
13 Transcranial Direct Current Stimulation in HIV-Infected, Depressed Persons Safety,Tolerability and Feasibility of tdcs for HIV+ Persons Racial and Ethnic Minorities with MDD tdcs was an Safe, effective and tolerable treatment in 7 HIV patients with co morbid major depression and associated with significant (P <.05) decreases in HAMD 24 and MADRAS scores (Rosedale & Knotkova, in review) 73 sessiopfc Phoressor II 850 PM using 2 electrodes (36cm 2 ) placed over F3 position of EEG system and the contralateral supraorbital region. Recruit racial/ethnic minorities HamD 24 and MADRAS Cytokine assays Analyze characteristics of completers/ non-completers Conduct qualitative interviews to incorporate subject input in future patient-centered treatment protocols Open label, 2 week block of tdcs (Baker, Rorden, & Fridriksson, 2010; Stroke) 74 A Treatment Wish List There is a very specific kind of pain to depression and it became less vicious. It was not that pain changed: the perception of pain changed (Rosedale, Lisanby & Malaspina, 2009) An evidence-based treatment for depression and pain Focus and dose that can be personalized Faster onset than medications Acceptable to those who cannot tolerate medications due to side effects, med interactions and comorbidities Adjuvant treatment for those reporting partial relief from other treatments (safely combined/optimizing response) Feasible for patients with low performance status (minimal patient effort or attention) Clinically tested in racial and ethnic minorities Well tolerated, brief, safe, easy to administer and inexpensive Key Issues: Reclassification of ECT by FDA and APNA s Position Statement ECT as evidence-based practice Unparalleled efficacy of ECT and dangers of limiting access Evolution of ECT and Brain Stimulation Misinformation and stigma of psychiatric conditions and treatments Key Issues at FDA hearings APNA s Vital Leadership Role and Position How History of Brain Stimulation Shapes Psychiatric Nursing s Future Advancing Evidence-based practice Combining Psychotherapeutic Treatments Combining Qualitative and Qualitative Approaches Treating new populations Advocating for Our Patients Influencing Public Policy Ecklesdafer, Rosedale, Miller, Mulder 13
14 APA ECT Task Force: APNA Consultation on Nurse s Role Second edition (2001) Third edition (2013) Evidence-based Nursing Practice and APN roles Accurately representing the wealth of psychiatric nursing expertise and the contributions of nursing profession 79 Life Long Neurogenesis: Olfactory System Olfactory Epithelium Culture Olfactory Neurons Gene Expression Studies Potential for Stem cells Hippocampal Dentate Gyrus Coronal and sagital 7T 100 micron cell layer Hippocampus 80 Translational Neuroscience Research Clinical Research Epidemiology Psychiatric Nursing and Brain Stimulation: Back to the Future Basic Science Animal Models Ecklesdafer, Rosedale, Miller, Mulder 14
Disclosures. Objectives. The Neurobiology of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health Nurses
The Neurobiology of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health Nurses American Psychiatric Nurses Association 26 th Annual Conference November 7, 2012 Pittsburgh, Pennsylvania
More informationObjectives. APNA 27th Annual Conference Session 1021: October 9, Brain Stimulation Techniques. Rosedale, Ecklesdafer, Kormos, Freedland, Knapp 1
The Significant Promise of Therapeutic Neuromodulation: Implications for Psychiatric Mental (PMH) Health Nursing Mary Rosedale PhD, PMHNP BC Donna Ecklesdafer, MSN, RN Theresa Kormos, MSN, PMHCNS BC Michelle
More informationBrain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN
Brain Stimulation American Psychiatric Nurses Association 24th Annual Conference October 16, 2010 Kentucky International Convention Center Louisville, Kentucky 1 Berry S. Anderson, PhD, RN Mary Rosedale,
More informationAPNA 25th Annual Conference October 19, Session 1035
1 Therapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses American Psychiatric Nurses Association 25 th Annual Conference October 19, 2011 Anaheim,
More informationTherapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses
Therapeutic Brain Stimulation: Past, Present, Future and Critical Issues for Psychiatric-Mental Health Nurses American Psychiatric Nurses Association 25 th Annual Conference October 19, 2011 Anaheim, California
More informationBrain Stimulation What Psychiatric Mental Health Nurses Need to Know
Brain Stimulation What Psychiatric Mental Health Nurses Need to Know Donna Ecklesdafer, MSN, BSN, RN Mary Rosedale PhD, PMHNP BC Paula Bolton MS, RN, ANP BC Mary Rosedale: Disclosures Edith L. Fisch Award
More informationPatient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
Dr. Zahida Tayyib www.mvptms.com Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder If you are considering Brainsway Deep treatment
More informationNeuromodulation Approaches to Treatment Resistant Depression
1 Alternative Treatments: Neuromodulation Approaches to Treatment Resistant Depression Audrey R. Tyrka, MD, PhD Assistant Professor Brown University Department of Psychiatry Associate Chief, Mood Disorders
More informationrtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies
rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Treatment Equipment rtms Equipment Positioning of coil ECT & rtms Innovative Treatment Options for Patients Only a fraction
More informationStatement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17
Statement on Repetitive Transcranial Magnetic Stimulation for Depression Position statement CERT03/17 Approved by the Royal College of Psychiatrists, Committee on ECT and Related Treatments: February 2017
More informationTranscranial Magnetic Stimulation for the Treatment of Depression
Transcranial Magnetic Stimulation for the Treatment of Depression Paul E. Holtzheimer, MD Associate Professor Departments of Psychiatry and Surgery Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock
More informationFrequently Asked Questions FAQS. NeuroStar TMS Therapies
Frequently Asked Questions FAQS NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 FAQS About TMS Therapies Page 1 NeuroStar
More informationDEEP TMS TREATMENT CONSENT FORM
DEEP TMS TREATMENT CONSENT FORM My doctor has recommended that I receive treatment with Brainsway Deep TMS. The nature of this treatment, including the benefits and risks that I may experience, has been
More informationTreatment of Depression: A Brief History
2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond
More informationFDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION
FOR IMMEDIATE RELEASE FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION First and Only Non-systemic and Non-invasive Treatment Cleared for Patients Who Have Not Benefited From Prior Antidepressant
More informationPatient Education Brief. NeuroStar TMS Therapies
Patient Education Brief NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 About Depression Depression is a serious medical
More informationThe New Clinical Science of ECT
The New Clinical Science of ECT C. Edward Coffey, MD Professor of Psychiatry & Behavioral Sciences, and of Neurology Baylor College of Medicine Houston, Texas Fellow and Past President, International Society
More informationAre you not responding to antidepressants?
PATIENTS & RELATIVES Are you not responding to antidepressants? TMS therapy might be the solution for you. Does not affect cognitive function No anesthesia Covered by most private providers Outpatient
More informationTodd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.
Transcranial Magnetic Stimulation: What You Need To Know Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D. Disclosures Todd Hutton, M.D. Speaker for Neuronetics Board of Directors,
More informationBRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?
BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION? Kira Stein, MD Medical Director West Coast Life Center Sherman Oaks, California CA Maternal Mental Health Initiative - 2013 2013
More informationLEASE DO NOT COPY. Setting up atms Clinic
Setting up atms Clinic Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center Contents Safety and training of personnel Equipment Certification
More informationSetting up atms Clinic. Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center
Setting up atms Clinic Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center Contents Safety and training of personnel Equipment Certification
More informationTMS: Full Board or Expedited?
TMS: Full Board or Expedited? Transcranial Magnetic Stimulation: - Neurostimulation or neuromodulation technique based on the principle of electro-magnetic induction of an electric field in the brain.
More informationAlcohol Opiates Other:
Pages 1 and 2 must be completed in full for all referrals (incomplete forms will not be processed) Additional Required Information Form must be completed for all referrals Medication Clinic (Pg. 3), ECT
More informationThe Next Chapter in Brain Stimulation Therapy
The Next Chapter in Brain Stimulation Therapy Outline I. Depression and Treatment Resistant Depression Barriers to Treatment Treatment Options Cost and Impact of Depression II. Electroconvulsive Therapy
More informationSetting up a TMS Treatment Program
Setting up a TMS Treatment Program Alvaro Pascual-Leone, M.D., Ph.D. Professor in Neurology Harvard Medical School Beth Israel Deaconess Medical Center Daniel Cohen, M.D., M.M.Sc. Instructor in Neurology
More informationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation Date of Origin: 7/24/2018 Last Review Date: 7/24/2018 Effective Date: 08/01/18 Dates Reviewed: 7/24/2018 Developed By: Medical Necessity Criteria Committee I. Description
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationOscar G. Morales. MD Founding Director McLean Hospital TMS
Institute of Medicine of the National Academies Non-Invasive Neuromodulation of the Central Nervous System: A Workshop Washington, DC. March 2 and 3, 2015 Session IV: Reimbursement Oscar G. Morales. MD
More informationWhat is Repetitive Transcranial Magnetic Stimulation?
rtms for Refractory Depression: Findings and Future Jonathan Downar, MD PhD Asst Professor, Dept of Psychiatry University of Toronto, Canada Co-Director, rtms Clinic Toronto Western Hospital University
More informationRepetitive transcranial magnetic stimulation for depression
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Repetitive transcranial magnetic stimulation for depression Depression causes low mood or sadness that can
More informationVO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT)
VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT) Diagnostic Guidelines: Introduction: Electroconvulsive Therapy has been in continuous use for more than 60 years. The clinical literature
More informationTranscranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications
Transcranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications Jon Draud, MS, MD Clinical Professor of Psychiatry University of Tennessee College of Medicine Memphis, Tennessee
More informationBME 701 Examples of Biomedical Instrumentation. Hubert de Bruin Ph D, P Eng
BME 701 Examples of Biomedical Instrumentation Hubert de Bruin Ph D, P Eng 1 Instrumentation in Cardiology The major cellular components of the heart are: working muscle of the atria & ventricles specialized
More informationSome newer, investigational approaches to treating refractory major depression are being used.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular
More informationAP PSYCH Unit 13.3 Biomedical Therapies
AP PSYCH Unit 13.3 Biomedical Therapies Prescribed medications or medical procedures that act directly on the patient s nervous system. Drugs that alter brain chemistry Affecting brain circuitry with electric
More information(U) USSOCOM. (U) Magnetic qeeg guided Resonance Therapy (MeRT)
United States Special Operations Command (U) USSOCOM MeRT Clinical Trial for Treatment of TBI COL Mark Baggett, Ph.D., US Army USSOCOM Command Psychologist Date: 14 Feb 2018 1 (U) Magnetic qeeg guided
More informationRepetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders
Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders Policy Number: Original Effective Date: MM.12.015 08/01/2014 Line(s)
More informationNOW I M A NEUROSTAR. Let Your Best Self Shine
NOW I M A NEUROSTAR. Let Your Best Self Shine It s Time for a New You NeuroStar Advanced Therapy is an in-office treatment that requires no anesthesia or sedation. You are awake and alert during treatment
More informationRemission From Depression Is Possible
Remission From Depression Is Possible About Depression Over 350 million people worldwide suffer from depression 1 While medications may help manage symptoms of depression, many patients are not satisfied
More informationHelp and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication
Help and Healing: Resources for Depression Care and Recovery Section 2: Treatment Planning Treatment and Timelines Depression Treatment Reference Care Team Communication Provider Education Tool - Questions
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Transcranial Magnetic Stimulation (TMS) Page 1 of 21 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS) Vagus Nerve
More informationIEHP UM Subcommittee Approved Authorization Guidelines Electroconvulsive Therapy- ECT
Electroconvulsive Therapy- ECT Policy: IEHP considers ECT medically necessary for members with the following disorders: 1. Unipolar and bipolar depression. 2. Bipolar mania. 3. Psychotic disorders including
More informationDepression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people
Content Depression Dr. Anna Lam Associate Consultant Department of Psychiatry, Queen Mary Hospital Honorary Clinical Assistant Professor Li Ka Shing Faculty of Medicine, The University of Hong Kong 1.
More informationAmerican University of Beirut University of Minnesota present. Depression: A complex landscape
Medial and Lateral Prefrontal Cortex Neuromodulation Therapies in Depression: A Continuum Ziad Nahas, MD, MSCR Professor and Vice Chair for Clinical Affairs Department of Psychiatry; University of Minnesota
More informationElectro-Convulsive Therapy Goals. Electro-Convulsive Therapy: Update Ambulatory Surgery Center at UCSF. Outline
: Update 2008 Descartes Li, M.D. Associate Clinical Professor Department of Psychiatry University of California, San Francisco Goals By the end of the seminar, a participant should be able to: Describe
More information2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.
Neuromodulation Techniques: State of the Science Philip G. Janicak, MD Adjunct Professor Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine Consultant
More informationOriginal Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression
Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression Guidance Number: MCG-104 Revision Date(s): Original Effective Date: 8/28/2013 Medical Coverage Guidance Approval Date: 8/28/2013
More informationPsychopharmacology 1: ECT
Psychopharmacology 1: ECT Paul Glue paul.glue@otago.ac.nz August 2017 How do antidepressants work? Early theories neurotransmitter deficiency - Unable to demonstrate; doesn t account for diversity of antidepressant
More informationRepetitive Transcranial Magnetic Stimulation (rtms)
Page 1 of 33 Medical Policies - Mental Health Repetitive Transcranial Magnetic Stimulation (rtms) Print Number: PSY301.015 Effective Date: 07-01-2014 Coverage: Initial rtms Treatment Repetitive transcranial
More informationCase 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1
Case 2:15-cv-07074-MWF-JPR Document 65-10 Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1 Case 2:15-cv-07074-MWF-JPR Document 65-10 Filed 03/20/17 Page 2 of 36 Page ID #:389 Cigna Medical Coverage
More informationMental Health Rotation Educational Goals & Objectives
Mental Health Rotation Educational Goals & Objectives Mental illness is prevalent in the general population and is commonly seen and treated in the office of the primary care provider. Educational experiences
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationTranscranial Magnetic Stimulation (TMS)
Transcranial Magnetic Stimulation (TMS) The treatment coil produces MRI-strength magnetic field pulses. Magnetic field pulses pass unimpeded through the cranium for 2-3 cm. and induce a small electric
More informationTranscranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Policy Number: 2.01.50 Last Review: 10/2017 Origination:
More informationSubthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about
More informationBiological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy
Biological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy Basic trainee talk 23 May 2007 ECT When is ECT used. Depression. Severe, melancholic. Resistant to treatment.
More informationTRANSCRANIAL MAGNETIC STIMULATION: CLINICAL UPDATE FOR PSYCHIATRIC APPLICATIONS ANNA MAZUR, PH.D. OSU DEPT. OF PSYCHIATRY AND BEHAVIORAL SCIENCES
TRANSCRANIAL MAGNETIC STIMULATION: CLINICAL UPDATE FOR PSYCHIATRIC APPLICATIONS ANNA MAZUR, PH.D. OSU DEPT. OF PSYCHIATRY AND BEHAVIORAL SCIENCES FINANCIAL DISCLOSURE I have financial relationships to
More informationa proven non-drug treatment for depression Get back to well without medication side effects right in your doctor s office.
a proven non-drug treatment for depression Get back to well......without medication side effects......right in your doctor s office. Is NeuroStar TMS Therapy right for you? 1) Are you are taking medication
More informationObjectives. APNA 26th Annual Conference Session 3022: Friday, November 9, Rosedale 1. Disclosures
Mary Rosedale PhD, PMHNP-BC Assistant Professor of Nursing and Psychiatry, NYU Institute for Social and Psychiatric Initiatives, Research Education and Service (InSPIRES), NYU Division of Brain Stimulation
More informationª The Author(s) The Canadian Journal of Psychiatry / La Revue Canadienne de Psychiatrie 1-15
Canadian Psychiatric Association Association des psychiatres du Canada Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive
More informationIntroduction to TMS Transcranial Magnetic Stimulation
Introduction to TMS Transcranial Magnetic Stimulation Lisa Koski, PhD, Clin Psy TMS Neurorehabilitation Lab Royal Victoria Hospital 2009-12-14 BIC Seminar, MNI Overview History, basic principles, instrumentation
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
of Depression and Other Psychiatric Disorders Page 1 of 26 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS)
More informationMayo Clin Proc, June 2002, Vol 77 Treatment of Medication-Refractory Mental Illness 553 Figure 1. Bitemporal electrode placement (left), unilateral el
552 Concise Review for Clinicians Electroconvulsive Therapy and Newer Modalities for the Treatment of Medication-Refractory Mental Illness KEITH G. RASMUSSEN, MD; SHIRLENE M. SAMPSON, MD; AND TERESA A.
More informationTHE PRACTICE OF ECT. Kiran Rabheru
THE PRACTICE OF ECT Kiran Rabheru MD, CCFP, FRCP Geriatric Psychiatrist Professor University of Ottawa February 11, 2015 U of Ottawa Review Course in Psychiatry: Dr. K. Rabheru 1 Disclosures n NONE 2 Learning
More informationPsychology in Your Life
Sarah Grison Todd Heatherton Michael Gazzaniga Psychology in Your Life SECOND EDITION Chapter 2 The Role of Biology in Psychology 1 2016 W. W. Norton & Company, Inc. 2.1 How Do Our Nervous Systems Affect
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Transcranial Magnetic Stimulation (TMS) Page 1 of 24 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS) Vagus Nerve
More informationTherapeutic Uses of Noninvasive Brain Stimulation Current & Developing
Therapeutic Uses of Noninvasive Brain Stimulation Current & Developing Alvaro Pascual-Leone, MD, PhD Berenson-Allen Center for Noninvasive Brain Stimulation Harvard Catalyst Beth Israel Deaconess Medical
More informationNEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'
NEURONETICS 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' 510(k) Owner: Neuronetics, Inc. DEC 1 6 Z008 1 Great Valley Parkway, Suite 2 Malvern, PA 19355 Phone: 610-640-4202 Fax: 610-640-4206 Company Contact:
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationTranscranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Corporate Medical Policy
Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Corporate Medical Policy File name: Transcranial Magnetic Stimulation as a Treatment of Depression
More informationAging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health
Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in
More informationTherapeutic Neuromodulation: Overview of a Novel Treatment Platform
Therapeutic Neuromodulation: Overview of a Novel Treatment Platform David G. Brock, MD; and Mark A. Demitrack, MD Shutterstock David G. Brock, MD, is Medical Director, Neuronetics, Inc. Mark A. Demitrack,
More informationrtms (repetitive Transcranial Magnetic Stimulation) Referral Documentation Treatment Centre, Berrywood Hospital, Northampton / 91
rtms (repetitive Transcranial Magnetic Stimulation) Referral Documentation 4.3.5 Centre, Berrywood Hospital, Northampton 01604 685590 / 91 Email; Centre.Berrywood@nhft.nhs.uk Contents Medical Staff Documentation
More informationNoninvasive Neuromodulation Current State & Future Directions
Sarah H. Lisanby, MD Director, Translational Research Division Team B Lead BRAIN Initiative Chief, Noninvasive Neuromodulation Unit Noninvasive Neuromodulation Current State & Future Directions Experimental
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationMIND-CONTROLLED DRONES VIRTUAL REALITY WEIRD INVENTIONS KITCHEN CHEMISTRY
MIND-CONTROLLED DRONES VIRTUAL REALITY WEIRD INVENTIONS KITCHEN CHEMISTRY JULY/AUGUST 2017 VOL. 08 ISSUE 04 GAINESVILLE EDITION Ingenuity & exploration spark imagination to turn dreams into reality! Follow
More informationAcetylcholine (ACh) Action potential. Agonists. Drugs that enhance the actions of neurotransmitters.
Acetylcholine (ACh) The neurotransmitter responsible for motor control at the junction between nerves and muscles; also involved in mental processes such as learning, memory, sleeping, and dreaming. (See
More informationPOLICY TITLE: Transcranial Magnetic Stimulation (TMS)
Departmental Policy POLICY NO.: 200.02.101P POLICY TITLE: Transcranial Magnetic Stimulation (TMS) Submitted by: Daniel Castellanos, MD Title: Founding Chair, Department of Psychiatry & Behavioral Health
More informationPractice parameter for use of electroconvulsive therapy with adolescents.
Complete Summary GUIDELINE TITLE Practice parameter for use of electroconvulsive therapy with adolescents. BIBLIOGRAPHIC SOURCE(S) Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson
More informationTranscranial Magnetic Stimulation:
Transcranial Magnetic Stimulation: What has experience told us? Jonathan Downar MD PhD FRCPC MRI-Guided rtms Clinic University Health Network www.rtmsclinic.ca Disclosures Research funding: Canadian Institutes
More informationBright Nights: Understanding Depression
Bright Nights: Understanding Depression KEVIN SETHI, MD MARCH 18 TH, 2019 Objectives Features of Depression Facts and Myths Treatment Options Medications Neuromodulation Cognitive Behavioral Therapy Mindfulness
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationbiological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40
biological psychology, p. 40 The specialized branch of psychology that studies the relationship between behavior and bodily processes and system; also called biopsychology or psychobiology. neuroscience,
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationMending the Mind: treatment of the severely mentally ill
Mending the Mind: treatment of the severely mentally ill First, the bad news Mental Illness Prevalence: putting things in perspective --More than 54 million Americans have a mental disorder in any given
More informationBrian A. Coffman, PhD
Brian A. Coffman, PhD Research Instructor Department of Psychiatry University of Pittsburgh School of Medicine UPMC Western Psychiatric Hospital Pittsburgh, PA Dr. Brian Coffman is a Research Instructor
More informationThe Nervous System. Neuron 01/12/2011. The Synapse: The Processor
The Nervous System Neuron Nucleus Cell body Dendrites they are part of the cell body of a neuron that collect chemical and electrical signals from other neurons at synapses and convert them into electrical
More informationMood Disorders-Major Depression
Mood Disorders Paula Gibbs, MD Assistant Professor Department of Psychiatry Medical Director of 5West Med-Psych University of Utah Hospitals and Clinics Mood Disorders-Major Depression Key Points for Major
More informationBRAINSWAY DEEP TMS SYSTEM
510(K) SUMMARY JAN 0 72013 BRAINSWAY DEEP TMS SYSTEM Applicant Name: Company Name: Address: 510(k) Number K122288 Brainsway Ltd. 19 Hartumn St. (Bynet Bldg) Har Hotzvim, Jerusalem, ISRAEL 91451 Tel: +972-2-5813
More informationBringing. to patients with depression
Bringing to patients with depression Hope is knowing remission from depression is possible Depression is a serious illness that affects approximately 350 million people worldwide. 1 While medications may
More informationTranscranial direct current stimulation (tdcs)
Clinical Memorandum Transcranial direct current stimulation (tdcs) August 2018 Authorising Committee/Department: Responsible Committee Responsible Department: Document Code: Board Section of Electroconvulsive
More informationPhysiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR
Physiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR In Physiology Today What the Brain Does The nervous system determines states of consciousness and produces complex behaviors Any given neuron may
More informationPlease read the following important safety requirements before using the Thymatron System IV ECT Instrument.
Caution: Federal law restricts this device to sale by or on the order of a licensed physician. ECT is a complex medical procedure. Its proper and safe conduct requires a staff of licensed healthcare professionals
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abuse alcohol, aggression and, 52 53 substance, aggression and, 52 54 ACE. See Aid to Capacity Evaluation (ACE). AEDs. See Antiepileptic
More informationOrganization of the nervous system. The withdrawal reflex. The central nervous system. Structure of a neuron. Overview
Overview The nervous system- central and peripheral The brain: The source of mind and self Neurons Neuron Communication Chemical messengers Inside the brain Parts of the brain Split Brain Patients Organization
More information